A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC

Clinical trial NCT00369070 · TERMINATED

Trial details

NCT number: NCT00369070
Sponsor: Amgen
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Advanced Non-squamous NSCLC

Start date: 2007-01-31
Primary completion: 2008-04-23
Enrollment: 186

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.